Business Context and Reporting Period
This Form 8-K filing by Benitec Biopharma Inc. (BNTC) is dated June 5, 2020. The report addresses a change in the company's independent registered public accounting firm following the completion of the company's re-domiciliation from Benitec Biopharma Limited to a Delaware corporation on April 15, 2020.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and accounting firm transitions rather than financial performance data.
Material Changes
- Accounting Firm Change: The Audit Committee approved the engagement of Squar Milner LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2020.
- Previous Firm: Grant Thornton Audit Pty Ltd served as the auditor prior to the re-domiciliation and will continue to serve as the auditor for the fiscal years ended June 30, 2019, and 2018.
- Accounting Standards Transition: The company is preparing financial statements for fiscal years 2018 and 2019 in accordance with U.S. GAAP, transitioning from the International Accounting Standards (IFRS) previously used by Benitec Limited.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. Regarding risks and contingencies, the company explicitly states there were no disagreements with Grant Thornton on accounting principles, practices, or auditing scope during the fiscal years ended June 30, 2019 and 2018, or the subsequent period through June 5, 2020. Additionally, no "reportable events" occurred during these periods. The audit reports for the prior years did not contain adverse opinions, disclaimers, or qualifications regarding going concern or uncertainty.
Investor Verification Checklist
- Verify the transition of financial reporting from IFRS to U.S. GAAP for fiscal years 2018 and 2019.
- Confirm the engagement of Squar Milner LLP for the fiscal year ending June 30, 2020.
- Review the attached letter from Grant Thornton (Exhibit 16.1) to confirm their agreement with the disclosure regarding the change in auditors.
- Note that no financial performance metrics are disclosed in this specific filing.